Condition: Juvenile Myopia · Myopia · Sponsor: SightGlass Vision, Inc.
This is a randomized, controlled, open-label, evaluator-blinded, multicenter, clinical trial of 12-months duration to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses in reducing the progression of juvenile myopia in children of Chinese origin.
This description comes directly from the study's public registry record.
Jennifer S Hill, BS · 678-361-4877 · jhill@sightglassvision.com
Vanessa Tasso, MA, MBA · 949-751-7039 · vtasso@sightglassvision.com
Always discuss trial participation with your own doctor first.
| Aier Eye Hospital | Changsha, China | Recruiting |
| West China Hospital | Chengdu, China | Recruiting |
| Zhongshan Ophthalmic Center | Guangzhou, China | Not Yet Recruiting |
| Fudan University EENT | Shanghai, China | Recruiting |
| Tianjin Eye Hospital | Tianjin, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07008001